Lorazepam and Bendamustine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Bendamustine (bendamustine). Common drug interactions include neutropenia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Bendamustine. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Bendamustine?

Bendamustine has active ingredients of bendamustine. eHealthMe is studying from 9,508 Bendamustine users. Check the latest studies of Bendamustine.



On Jul, 16, 2026

55 people who take Lorazepam and Bendamustine together, and have interactions are studied.

Lorazepam and Bendamustine drug interactions.

What are the common drug interactions of Lorazepam and Bendamustine, by gender? *:

female:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pyrexia (fever)
  3. Hypotension (abnormally low blood pressure)
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  5. Blood lactate dehydrogenase increased
  6. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  7. Alanine aminotransferase increased
  8. Aspartate aminotransferase increased
  9. Blood alkaline phosphatase increased
  10. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

male:

  1. Pneumonia
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Acute respiratory failure
  5. Alopecia (absence of hair from areas of the body)
  6. Anaemia (lack of blood)
  7. Appendicitis (inflammation of the appendix)
  8. Blood lactate dehydrogenase increased
  9. Brain injury
  10. C-reactive protein increased

What are the common drug interactions of Lorazepam and Bendamustine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  4. Pyrexia (fever)
  5. Anaemia (lack of blood)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Hypotension (abnormally low blood pressure)
  8. Leukopenia (less number of white blood cells in blood)
  9. Pneumonia
  10. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

60+:

  1. Blood lactate dehydrogenase increased
  2. Pneumonia
  3. Blood albumin decreased
  4. Blood calcium decreased
  5. Blood glucose increased
  6. Blood phosphorus decreased
  7. Blood triglycerides increased
  8. Blood urea decreased
  9. Blood uric acid decreased
  10. Carbon dioxide decreased

What are the existing conditions these people have? *

  1. Burkitt Lymphoma (cancer of the lymphatic system): 22 people, 40.00%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 15 people, 27.27%
  3. Nausea (feeling of having an urge to vomit): 13 people, 23.64%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 18.18%
  5. High Blood Pressure: 9 people, 16.36%
  6. Immunodeficiency: 9 people, 16.36%
  7. Dyslipidaemia (abnormal amount of lipids): 9 people, 16.36%
  8. Fever: 8 people, 14.55%
  9. Constipation: 8 people, 14.55%
  10. Depression: 8 people, 14.55%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Bendamustine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lorazepam and Bendamustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bendamustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bendamustine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and bendamustine (the active ingredients of Lorazepam and Bendamustine, respectively), and Lorazepam and Bendamustine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: